
Organ-On-Chip Market Share, Size, Trends, Industry Analysis Report, By Organ Type (Heart, Lung, Liver, Intestine, and Kidney); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032
Description
Organ-On-Chip Market Share, Size, Trends, Industry Analysis Report, By Organ Type (Heart, Lung, Liver, Intestine, and Kidney); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032
The global organ-on-chip market size is expected to reach USD 1388.30 million by 2032, according to a new study by Polaris Market Research. The report “Organ-On-Chip Market Share, Size, Trends, Industry Analysis Report, By Organ Type (Heart, Lung, Liver, Intestine, and Kidney); By Application; By End-User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market for organs on chips is growing mostly because of government efforts to limit the use of animal models in drug testing. Variables like improvements in fabrication technologies and the growing acceptance of organ-on-chip technology by biotechnology and pharmaceutical businesses also aid the development of this industry. However, the poor throughput of existing organ-on-chip technology combined with the technical complexity of the organ-on-chip models presents a partial barrier to industry growth.
Since the onset of COVID-19, the biopharmaceutical industry and scientific community have become more proactive, making Organ-on-chip technology highly adaptable for developing medications and vaccines during the pandemic. In essence, the novel coronavirus has become a lucrative opportunity for the organ-on-a-chip sector, with continual growth anticipated in the forecast period.
Multi-organ-on-chip (MOC) systems have been created to mimic the functions of multiple organs and facilitate inter-organ communication. They are valuable for studying drug responses and assessing drug toxicity across various organs simultaneously. MOCs play a crucial role in safety assessments within the cosmetic and food industries, offering efficient compound testing methods without the need for animal testing.
In cosmetics, miniature human skin, eyes, and other relevant organ models enable the safety evaluation of ingredients and final products. MOCs can be customized with specific cells to study how unique skin biology interacts with certain compounds. By including digestive organs, MOCs can also evaluate nutrients for developing personalized and nutritious food items. These chips present an innovative approach to replacing traditional animal models and toxicity testing.
Organ-On-Chip Market Report Highlights
The drug discovery segment dominated the market in 2023, driven by significant demand for in vitro tissue models that replicate human organ functions to aid in drug development.
The pharmaceutical & biotechnology companies segment led the market in 2023 and is expected to maintain its dominance due to significant investments in research & development along with the requirement for advanced drug testing methods.
North America holds a significant revenue share in the global organ-on-chip market, driven by key market players and government initiatives.
The global key market players include AlveoliX AG, AxoSim, BICO - the bio convergence company, CN Bio Innovations Ltd, Emulate, Inc., MIMETAS B.V., Nortis, Inc., SynVivo, Inc., The Charles Stark Draper Laboratory, Inc, and Valo Health
Polaris Market Research has segmented the organ-on-chip market report based on type, application, end-user, and region:
Organ-On-Chip, Organ Type Outlook (Revenue - USD Million, 2019 - 2032)
Heart
Lung
Liver
Intestine
Kidney
Others
Organ-On-Chip, Application Outlook (Revenue - USD Million, 2019 - 2032)
Drug Discovery
Toxicology Research
Stem Cell Research
Physiological Model Development
Tissue Regeneration & Regenerative Medicines
Organ-On-Chip, End-User Outlook (Revenue - USD Million, 2019 - 2032)
Pharmaceutical & Biotechnology Companies
Academic and Research Institutes
Organ-On-Chip, Regional Outlook (Revenue - USD Million, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
115 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Organ-On-Chip Market Insights
- 4.1. Organ-On-Chip Market – Application Snapshot
- 4.2. Organ-On-Chip Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising demand of substitute to reduce animal drug experimentation
- 4.2.1.2. Integration of technologies such as microfluidics and tissue engineering
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Organ-on-a-chip applications are restricted to preclinical studies
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Organ-On-Chip Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Organ-On-Chip Market, by Organ Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 5.3. Heart
- 5.3.1. Global Organ-On-Chip Market, by Heart, by Region, 2019-2032 (USD Million)
- 5.4. Lung
- 5.4.1. Global Organ-On-Chip Market, by Lung, by Region, 2019-2032 (USD Million)
- 5.5. Liver
- 5.5.1. Global Organ-On-Chip Market, by Liver, by Region, 2019-2032 (USD Million)
- 5.6. Intestine
- 5.6.1. Global Organ-On-Chip Market, by Intestine, by Region, 2019-2032 (USD Million)
- 5.7. Kidney
- 5.7.1. Global Organ-On-Chip Market, by Kidney, by Region, 2019-2032 (USD Million)
- 5.8. Others
- 5.8.1. Global Organ-On-Chip Market, by Others, by Region, 2019-2032 (USD Million)
- 6. Global Organ-On-Chip Market, by End-User
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 6.3. Pharmaceutical & Biotechnology Companies
- 6.3.1. Global Organ-On-Chip Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
- 6.4. Academic and Research Institutes
- 6.4.1. Global Organ-On-Chip Market, by Academic and Research Institutes, by Region, 2019-2032 (USD Million)
- 7. Global Organ-On-Chip Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 7.3. Drug Discovery
- 7.3.1. Global Organ-On-Chip Market, by Drug Discovery, By Region, 2019-2032 (USD Million)
- 7.4. Toxicology Research
- 7.4.1. Global Organ-On-Chip Market, by Toxicology Research, By Region, 2019-2032 (USD Million)
- 7.5. Stem Cell Research
- 7.5.1. Global Organ-On-Chip Market, by Stem Cell Research, By Region, 2019-2032 (USD Million)
- 7.6. Physiological Model Development
- 7.6.1. Global Organ-On-Chip Market, by Physiological Model Development, By Region, 2019-2032 (USD Million)
- 7.7. Tissue Regeneration & Regenerative Medicines
- 7.7.1. Global Organ-On-Chip Market, by Tissue Regeneration & Regenerative Medicines, By Region, 2019-2032 (USD Million)
- 8. Global Organ-On-Chip Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Organ-On-Chip Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Organ-On-Chip Market – North America
- 8.3.1. North America: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.3.2. North America: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.3.3. North America: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.3.4. Organ-On-Chip Market – U.S.
- 8.3.4.1. U.S.: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.3.5. Organ-On-Chip Market – Canada
- 8.3.5.1. Canada: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4. Organ-On-Chip Market – Europe
- 8.4.1. Europe: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.3. Europe: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4.4. Organ-On-Chip Market – UK
- 8.4.4.1. UK: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.4.3. UK: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4.5. Organ-On-Chip Market – France
- 8.4.5.1. France: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.5.3. France: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4.6. Organ-On-Chip Market – Germany
- 8.4.6.1. Germany: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4.7. Organ-On-Chip Market – Italy
- 8.4.7.1. Italy: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4.8. Organ-On-Chip Market – Spain
- 8.4.8.1. Spain: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4.9. Organ-On-Chip Market – Netherlands
- 8.4.9.1. Netherlands: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.4.10. Organ-On-Chip Market – Russia
- 8.4.10.1. Russia: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.5. Organ-On-Chip Market – Asia Pacific
- 8.5.1. Asia Pacific: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.5.4. Organ-On-Chip Market – China
- 8.5.4.1. China: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.5.4.3. China: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.5.5. Organ-On-Chip Market – India
- 8.5.5.1. India: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.5.5.3. India: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.5.6. Organ-On-Chip Market – Malaysia
- 8.5.6.1. Malaysia: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.5.7. Organ-On-Chip Market – Japan
- 8.5.7.1. Japan: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.5.8. Organ-On-Chip Market – Indonesia
- 8.5.8.1. Indonesia: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.5.9. Organ-On-Chip Market – South Korea
- 8.5.9.1. South Korea: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.6. Organ-On-Chip Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.6.4. Organ-On-Chip Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.6.5. Organ-On-Chip Market – UAE
- 8.6.5.1. UAE: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.6.6. Organ-On-Chip Market – Israel
- 8.6.6.1. Israel: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.6.7. Organ-On-Chip Market – South Africa
- 8.6.7.1. South Africa: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.7. Organ-On-Chip Market – Latin America
- 8.7.1. Latin America: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.7.3. Latin America: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.7.4. Organ-On-Chip Market – Mexico
- 8.7.4.1. Mexico: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.7.5. Organ-On-Chip Market – Brazil
- 8.7.5.1. Brazil: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 8.7.6. Organ-On-Chip Market – Argentina
- 8.7.6.1. Argentina: Organ-On-Chip Market, by Organ Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Organ-On-Chip Market, by Application, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Organ-On-Chip Market, by End-User, 2019-2032 (USD Million)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. AlveoliX AG
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AxoSim
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. BICO - THE BIO CONVERGENCE COMPANY
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. CN Bio Innovations Ltd
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Emulate, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. MIMETAS B.V
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Nortis, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. SynVivo, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. The Charles Stark Draper Laboratory, Inc
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Valo Health
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.